BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34361836)

  • 1. Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice.
    Chang GR; Kuo CY; Tsai MY; Lin WL; Lin TC; Liao HJ; Chen CH; Wang YC
    Molecules; 2021 Aug; 26(15):. PubMed ID: 34361836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anti-Cancer Effects of a Zotarolimus and 5-Fluorouracil Combination Treatment on A549 Cell-Derived Tumors in BALB/c Nude Mice.
    Wu CF; Wu CY; Chiou RY; Yang WC; Lin CF; Wang CM; Hou PH; Lin TC; Kuo CY; Chang GR
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
    Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
    World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic effect of rapamycin combined with 5-fluorouracil in BALB/cByJNarl mice bearing CT-26 tumor cells.
    Chao TH; Chang GR; Chen WY; Chen PL; Mao FC
    Anticancer Res; 2014 Jul; 34(7):3329-35. PubMed ID: 24982337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice.
    Liu L; Qiu S; Liu Y; Liu Z; Zheng Y; Su X; Chen B; Chen H
    Neoplasma; 2016; 63(2):193-200. PubMed ID: 26774139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer.
    Wang K; Liu W; Xu Q; Gu C; Hu D
    Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis.
    Chong D; Ma L; Liu F; Zhang Z; Zhao S; Huo Q; Zhang P; Zheng H; Liu H
    Anticancer Drugs; 2017 Sep; 28(8):831-840. PubMed ID: 28816773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice.
    Wu CF; Wu CY; Lin CF; Liu YW; Lin TC; Liao HJ; Chang GR
    Biomed Pharmacother; 2022 Jul; 151():113128. PubMed ID: 35609368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations.
    Jia YT; Yang DH; Zhao Z; Bi XH; Han WH; Feng B; Zhi J; Gu B; Duan Z; Wu JH; Ju YC; Wang MX; Li ZX
    Curr Cancer Drug Targets; 2018; 18(3):278-286. PubMed ID: 28359236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
    de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
    PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer.
    Khan N; Jajeh F; Eberhardt EL; Miller DD; Albrecht DM; Van Doorn R; Hruby MD; Maresh ME; Clipson L; Mukhtar H; Halberg RB
    Int J Cancer; 2019 Dec; 145(11):3022-3032. PubMed ID: 31018249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
    Zhu G; Zhao M; Han Q; Tan Y; Sun YU; Bouvet M; Singh SR; Ye J; Hoffman RM
    Anticancer Res; 2019 Nov; 39(11):5999-6005. PubMed ID: 31704825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling.
    Quan Q; Zhong F; Wang X; Chen K; Guo L
    Oncol Res; 2019 Jul; 27(7):779-788. PubMed ID: 30841957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
    Gazit Z; Weiss DW; Shouval D; Yechezkeli M; Schirrmacher V; Notter M; Walter J; Kedar E
    Cancer Immunol Immunother; 1992; 35(2):135-44. PubMed ID: 1596937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
    Martinelli E; Troiani T; Morgillo F; Rodolico G; Vitagliano D; Morelli MP; Tuccillo C; Vecchione L; Capasso A; Orditura M; De Vita F; Eckhardt SG; Santoro M; Berrino L; Ciardiello F
    Clin Cancer Res; 2010 Oct; 16(20):4990-5001. PubMed ID: 20810384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.